| 000 | 01237 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250516193452.0 | ||
| 264 | 0 | _c20140604 | |
| 008 | 201406s 0 0 eng d | ||
| 022 | _a0946-1965 | ||
| 024 | 7 |
_a10.5414/CP202033 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFujimoto, Mai | |
| 245 | 0 | 0 |
_aStatin-associated lower urinary tract symptoms: data mining of the public version of the FDA adverse event reporting system, FAERS. _h[electronic resource] |
| 260 |
_bInternational journal of clinical pharmacology and therapeutics _cApr 2014 |
||
| 300 |
_a259-66 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdverse Drug Reaction Reporting Systems |
| 650 | 0 | 4 | _aData Mining |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydroxymethylglutaryl-CoA Reductase Inhibitors _xadverse effects |
| 650 | 0 | 4 |
_aLower Urinary Tract Symptoms _xchemically induced |
| 650 | 0 | 4 | _aUnited States |
| 650 | 0 | 4 | _aUnited States Food and Drug Administration |
| 700 | 1 | _aHosomi, Kouichi | |
| 700 | 1 | _aTakada, Mitsutaka | |
| 773 | 0 |
_tInternational journal of clinical pharmacology and therapeutics _gvol. 52 _gno. 4 _gp. 259-66 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.5414/CP202033 _zAvailable from publisher's website |
| 999 |
_c23493515 _d23493515 |
||